256 related articles for article (PubMed ID: 28183292)
1. Case report: rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene.
Mudry P; Slaby O; Neradil J; Soukalova J; Melicharkova K; Rohleder O; Jezova M; Seehofnerova A; Michu E; Veselska R; Sterba J
BMC Cancer; 2017 Feb; 17(1):119. PubMed ID: 28183292
[TBL] [Abstract][Full Text] [Related]
2. Effects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a
Sramek M; Neradil J; Macigova P; Mudry P; Polaskova K; Slaby O; Noskova H; Sterba J; Veselska R
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30200486
[TBL] [Abstract][Full Text] [Related]
3. PDGFRB gain-of-function mutations in sporadic infantile myofibromatosis.
Arts FA; Sciot R; Brichard B; Renard M; de Rocca Serra A; Dachy G; Noël LA; Velghe AI; Galant C; Debiec-Rychter M; Van Damme A; Vikkula M; Helaers R; Limaye N; Poirel HA; Demoulin JB
Hum Mol Genet; 2017 May; 26(10):1801-1810. PubMed ID: 28334876
[TBL] [Abstract][Full Text] [Related]
4. Infantile Myofibromatosis With Intracranial Extradural Involvement and PDGFRB Mutation: A Case Report and Review of the Literature.
Al Qawahmed R; Sawyer SL; Vassilyadi M; Qin W; Boycott KM; Michaud J
Pediatr Dev Pathol; 2019; 22(3):258-264. PubMed ID: 30103666
[TBL] [Abstract][Full Text] [Related]
5. Novel
Hassan M; Butler E; Wilson R; Roy A; Zheng Y; Liem P; Rakheja D; Pavlick D; Young LL; Rosenzweig M; Erlich R; Ali SM; Leavey PJ; Parsons DW; Skapek SX; Laetsch TW
Cold Spring Harb Mol Case Stud; 2019 Oct; 5(5):. PubMed ID: 31645346
[TBL] [Abstract][Full Text] [Related]
6. A recurrent PDGFRB mutation causes familial infantile myofibromatosis.
Cheung YH; Gayden T; Campeau PM; LeDuc CA; Russo D; Nguyen VH; Guo J; Qi M; Guan Y; Albrecht S; Moroz B; Eldin KW; Lu JT; Schwartzentruber J; Malkin D; Berghuis AM; Emil S; Gibbs RA; Burk DL; Vanstone M; Lee BH; Orchard D; Boycott KM; Chung WK; Jabado N
Am J Hum Genet; 2013 Jun; 92(6):996-1000. PubMed ID: 23731537
[TBL] [Abstract][Full Text] [Related]
7. PDGRFB mutation-associated myofibromatosis: Response to targeted therapy with imatinib.
Weller JM; Keil VC; Gielen GH; Herrlinger U; Schäfer N
Am J Med Genet A; 2019 Sep; 179(9):1895-1897. PubMed ID: 31291054
[TBL] [Abstract][Full Text] [Related]
8. Modulation of expressivity in PDGFRB-related infantile myofibromatosis: a role for PTPRG?
Linhares ND; Freire MC; Cardenas RG; Bahia M; Puzenat E; Aubin F; Pena SD
Genet Mol Res; 2014 Aug; 13(3):6287-92. PubMed ID: 25158255
[TBL] [Abstract][Full Text] [Related]
9. PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib.
Arts FA; Chand D; Pecquet C; Velghe AI; Constantinescu S; Hallberg B; Demoulin JB
Oncogene; 2016 Jun; 35(25):3239-48. PubMed ID: 26455322
[TBL] [Abstract][Full Text] [Related]
10. Heterozygous PDGFRB Mutation in a Three-generation Family with Autosomal Dominant Infantile Myofibromatosis.
Lepelletier C; Al-Sarraj Y; Bodemer C; Shaath H; Fraitag S; Kambouris M; Hamel-Teillac D; El Shanti H; Hadj-Rabia S
Acta Derm Venereol; 2017 Jul; 97(7):858-859. PubMed ID: 28417142
[No Abstract] [Full Text] [Related]
11. The spectrum of infantile myofibromatosis includes both non-penetrance and adult recurrence.
Murray N; Hanna B; Graf N; Fu H; Mylène V; Campeau PM; Ronan A
Eur J Med Genet; 2017 Jul; 60(7):353-358. PubMed ID: 28286173
[TBL] [Abstract][Full Text] [Related]
12. Treatment of generalized infantile myofibromatosis with sorafenib and imatinib: A case report.
Bidadi B; Watson A; Weigel B; Oliveira A; Kirkham J; Arndt C
Pediatr Blood Cancer; 2020 Jun; 67(6):e28288. PubMed ID: 32307894
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of life-threatening generalized infantile myofibromatosis using low-dose chemotherapy.
Gandhi MM; Nathan PC; Weitzman S; Levitt GA
J Pediatr Hematol Oncol; 2003 Sep; 25(9):750-4. PubMed ID: 12972815
[TBL] [Abstract][Full Text] [Related]
14. A patient with germ-line gain-of-function PDGFRB p.N666H mutation and marked clinical response to imatinib.
Pond D; Arts FA; Mendelsohn NJ; Demoulin JB; Scharer G; Messinger Y
Genet Med; 2018 Jan; 20(1):142-150. PubMed ID: 28726812
[TBL] [Abstract][Full Text] [Related]
15. A novel de novo PDGFRB variant in a child with severe cerebral malformations, intracerebral calcifications, and infantile myofibromatosis.
Guimier A; Gordon CT; Hully M; Blauwblomme T; Minard-Colin V; Bole-Feysot C; Nitschké P; Oufadem M; Boddaert N; Sarnacki S; Amiel J
Am J Med Genet A; 2019 Jul; 179(7):1304-1309. PubMed ID: 31004414
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy for Generalized Infantile Myofibromatosis With Visceral Involvement.
Wu SY; McCavit TL; Cederberg K; Galindo RL; Leavey PJ
J Pediatr Hematol Oncol; 2015 Jul; 37(5):402-5. PubMed ID: 24608078
[TBL] [Abstract][Full Text] [Related]
17. Major response to imatinib and chemotherapy in a newborn patient prenatally diagnosed with generalized infantile myofibromatosis.
Proust S; Benchimol G; Fraitag S; Starck J; Giacobbi V; Pierron G; Bodemer C; Orbach D
Pediatr Blood Cancer; 2021 Jan; 68(1):e28576. PubMed ID: 32896962
[No Abstract] [Full Text] [Related]
18. Mutations in PDGFRB cause autosomal-dominant infantile myofibromatosis.
Martignetti JA; Tian L; Li D; Ramirez MC; Camacho-Vanegas O; Camacho SC; Guo Y; Zand DJ; Bernstein AM; Masur SK; Kim CE; Otieno FG; Hou C; Abdel-Magid N; Tweddale B; Metry D; Fournet JC; Papp E; McPherson EW; Zabel C; Vaksmann G; Morisot C; Keating B; Sleiman PM; Cleveland JA; Everman DB; Zackai E; Hakonarson H
Am J Hum Genet; 2013 Jun; 92(6):1001-7. PubMed ID: 23731542
[TBL] [Abstract][Full Text] [Related]
19. [Sporadic infantile myofibromatosis: Mutations with PDGFRB gain-of-function].
Dereure O
Ann Dermatol Venereol; 2017; 144(8-9):574-575. PubMed ID: 28756885
[No Abstract] [Full Text] [Related]
20. Prenatal genetic diagnosis of disseminated infantile myofibromatosis: a case report and literature review.
Lü Y; Jiang Y; Wu H; Qi Q; Zhou X; Guo Q; Hao N; Liu J; Meng H
BMC Med Genomics; 2023 Aug; 16(1):185. PubMed ID: 37568122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
